Revolutionizing Targeted Care: How Antibody-Drug Conjugates are...

ha aggiunto una foto Health

2025-12-04 16:49:59 -

Revolutionizing Targeted Care: How Antibody-Drug Conjugates are Changing the Treatment Paradigm for Advanced HER2-Positive Disease

The field of targeted oncology has seen a significant leap forward with the advent of Antibody-Drug Conjugates, or ADCs, which represent a sophisticated approach often described as "smart chemotherapy." These agents consist of an anti-HER2 monoclonal antibody (like Trastuzumab) chemically linked to a potent cytotoxic chemotherapy drug (the payload). The antibody component is designed to seek...

0 Commenti 0 condivisioni 209 Views 0 Anteprima